1 Product identity
Ingredient risk
No flagged ingredients

CordySeng

BrandHealth ConcernsOther Combinations Tablet or Pill 11 ingredients DSLD #72828
Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2017-04-25
2 Ingredients (11)
IngredientGroupSafety
Proprietary BlendProprietary Blend
CordycepsCordycepsConditionally Safe
Red Ganoderma ReishiReishi mushroom
AstragalusAstragalusGenerally Safe
American GinsengAmerican Ginseng
LicoriceLicorice
GingerGinger
Vegetable Gumvegetable gum (unspecified)
Silicon DioxideSiliconGenerally Safe
Stearic AcidStearic Acid
CelluloseCellulose
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Cordyceps — Conditionally Safe
⚠ May slow blood clotting
⚠ May lower blood glucose
Reishi — Limited Evidence
⚠ Hepatotoxicity (rare, powdered form)
⚠ Antiplatelet effect
Astragalus — Generally Safe
⚠ Immunostimulatory
⚠ May lower blood glucose
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID72828
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2017-04-25
6 More from Health Concerns
View Health Concerns Safety Scorecard → 25 products
AC-Q Tabs SilerAdrenosenCalm SpiritCir-QClear HeatColostroplex
7 Cite this page
Vancouver
Pkhakadze G. CordySeng — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Sep 01]. Available from: https://supplement.ge/products/cordyseng-72828/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network